Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Com Stk Usd0.01 [Di] (MXCT.LN)

Com Stk Usd0.01 [Di] (MXCT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Com Stk Usd0.01 [Di] 9713 Key West Avenue Suite 400 Rockville MD 20850 USA

https://www.maxcyte.com P: 301-944-1700 F: 301-944-1703

Description:

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Key Statistics

Overview:

Market Capitalization, $K 323,042
Shares Outstanding, K 104,544
Annual Sales, $ 41,288 K
Annual Net Income, $ -37,923 K
Last Quarter Sales, $ 11,342 K
Last Quarter Net Income, $ -9,526 K
% of Insider Shareholders 1.66%
% of Institutional Shareholders 44.40%

Growth:

1-Year Return -11.98%
3-Year Return -70.29%
5-Year Return 138.58%
5-Year Revenue Growth 19.89%

Per-Share Information:

Most Recent Earnings -0.09 on 05/08/24
Next Earnings Date N/A
Earnings Per Share ttm -0.35
EPS Growth vs. Prev Year 16.18%
Dividend Payout Ratio 0.00%

MXCT.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -15.42%
Return-on-Assets % -13.56%
Profit Margin % -91.85%
Debt/Equity 0.08
Price/Sales 9.04
Price/Book 1.80
Book Value/Share 1.71
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar